/Companies

Curegenix Corporation

1 known investors

Find your way into Curegenix Corporation

Sign up to see every warm intro you have to Curegenix Corporation

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Curegenix Corporation team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Curegenix is a clinical-stage biopharmaceutical company founded in 2009 that develops small-molecule drugs targeting the WNT signaling pathway, including lead candidate CGX1321, for cancer and tissue repair, with operations in California and Guangzhou, China.

Investors · 1

Frequently asked questions

What does Curegenix Corporation do?
Curegenix is a clinical-stage biopharmaceutical company founded in 2009 that develops small-molecule drugs targeting the WNT signaling pathway, including lead candidate CGX1321, for cancer and tissue repair, with operations in California and Guangzhou, China.
Who are Curegenix Corporation's investors?
Curegenix Corporation's investors include F-Prime Capital.